• Ann. Intern. Med. · Jun 2014

    Observational Study

    Prevention of vertical transmission of hepatitis B: an observational study.

    • Ai Kubo, Lyle Shlager, Amy R Marks, Dena Lakritz, Colette Beaumont, Kim Gabellini, and Douglas A Corley.
    • Ann. Intern. Med. 2014 Jun 17; 160 (12): 828-35.

    BackgroundFor mothers with chronic hepatitis B virus (HBV) infection, the Centers for Disease Control and Prevention recommends immunoprophylaxis to decrease perinatal transmission. However, its effectiveness and risk factors for failure have not been well-studied in community practice.ObjectiveTo investigate the effectiveness of a contemporary immunoprophylaxis protocol.DesignObservational study.SettingAn HBV perinatal immunoprophylaxis program within Kaiser Permanente Northern California.Patients4446 infants born to 3253 HBV-positive mothers between 1997 and 2010.MeasurementsAdherence to immunoprophylaxis, follow-up testing rates, maternal risk factors for HBV transmission, and transmission rates.ResultsThe infant infection rate was 0.75 per 100 births from 1997 to 2010 (Poisson 95% CI, 0.48 to 1.10). Rates per 100 births were 3.37 (CI, 2.08 to 5.14) for e antigen-positive mothers and 0.04 (CI, 0.001 to 0.24) for e antigen-negative mothers. Among mothers with viral load testing, the lowest level associated with transmission was 6.32 × 107 IU/mL. Infection rates per 100 births were 3.61 (CI, 0.75 to 10.56) among the 83 births to mothers with viral loads of 5 × 107 IU/mL or greater and 0 among the 831 births to mothers with viral loads less than 5 × 107 IU/mL, regardless of e antigen status.LimitationsTesting for HBV immunity and infection was less complete in earlier years. Viral load testing was only consistently available starting in 2007.ConclusionPrenatal HBV screening followed by postnatal prophylaxis is highly effective in preventing vertical transmission of HBV. A negative e antigen status or a viral load less than 5 × 107 IU/mL (90.9% of women tested) identifies women at extremely low risk for transmission after immunoprophylaxis who are unlikely to benefit from further interventions.Primary Funding SourceKaiser Permanente Community Benefit and National Institutes of Health.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.